Search results for: Value-Based Pricing
Filter search results
Changes in Determining Medicines Pricing in France, Germany and the UK
24 January 2013
…the emphasis of the recent reforms is centred around evidence requirements and, in particular, the choice of comparators and the use of head-to-head trials. In the UK, however, value-based pricing…
An Update on the EQ-5D-5L Value Set for England
22 August 2017
…on the implications of new value sets for HTA and other uses. 1. What is the current status of the EQ-5D-5L value set for England? An English value set for…
New: Operationalising Value Based Pricing
11 August 2011
…the full set of possible means by which value based pricing might be operationalised, categorise these by developing a taxonomy of approaches, and provide an initial assessment of the challenges,…
Why we need a new Outcomes-based Value Attribution Framework for Combination Regimens in Oncology
1 February 2021
…L., and Bruce, A., 2021. Why we need a new Outcomes-based Value Attribution Framework for Combination Regimens in Oncology. OHE Consulting Report, London: Office of Health Economics. Available at: https://www.ohe.org/publications/why-we-need-new-outcomes-based-value-attribution-framework-combination-regimens…
Experience-Based Values: A Framework for Classifying Different Types of Experience in Health Valuation Research
7 February 2018
…focuses on eliciting values from the perspective of those who have experience with the health state being valued, or those who do not. Value sets purporting to present experience-based (EB)…
The WHO Technical Report on the Pricing of Cancer Medicines: Missing a central role for HTA and value assessment
1 April 2019
…Report fails to promote mechanisms and processes (value assessment and related pricing and purchasing arrangements) that are key to efficient pricing and use of cancer medicines. This is a missed…
OHE Launches Discussion Paper and Consultation Exercise on Indication-based Pricing
10 May 2019
Increasingly, scientific advances are delivering new medicines that deliver improved survival and quality of life across multiple treatment indications. Indication-Based Pricing (IBP) has been proposed as a way to better…
Establishing a Reasonable Price for an Orphan Drug
11 September 2020
…et al., 2019. Value-Based Pricing for Emerging Gene Therapies: The Economic Case for a Higher Cost-Effectiveness Threshold. J Manag Care Spec Pharm, 2019 Jul;25(7):793-799 Lakdawalla and Phelps, 2020. Health technology…
A Final MVAC Blueprint—and the Start of an R&D Revolution?
6 February 2020
…Blueprint for a Market-Driven Value-Based Advance Commitment (MVAC) for Tuberculosis. Center for Global Development. Available at: https://www.cgdev.org/publication/blueprint-market-driven-value-based-advance-commitment-tuberculosis Related research Chalkidou, K., Garau, M., Nemzoff,C., Rodes-Sanchez, M., Silverman, R., and Towse A. (2019). Blueprint…